Discover and read the best of Twitter Threads about #CLSA
Most recents (2)
DEBT in #Adanigroup, worries you?
ACTUALLY aggregate debt levels of Adani group has improved over the years & Ebitda/Debt levels are much healthy now.
Get FULL clarity in this 5 page report by #CLSA :
"Where does all the Debt of
@gautam_adani group of
companies actually SIT"!
🧵
ACTUALLY aggregate debt levels of Adani group has improved over the years & Ebitda/Debt levels are much healthy now.
Get FULL clarity in this 5 page report by #CLSA :
"Where does all the Debt of
@gautam_adani group of
companies actually SIT"!
🧵
Page 1 
Page 2
@SunPharma_Live
(In Million) fy11/fy20
Revenue - 60827/334735
R&D - 3313/19736
Net Profit - 18161/69644
EPS - 7.5/15.7
New speciality launche
1) Cequa -Oct'19 (cyclosporine ophthalmic solution 0.09%)in Keratoconjunctivitis sicca(dry eye) for increasing tear productn
#pharma
(In Million) fy11/fy20
Revenue - 60827/334735
R&D - 3313/19736
Net Profit - 18161/69644
EPS - 7.5/15.7
New speciality launche
1) Cequa -Oct'19 (cyclosporine ophthalmic solution 0.09%)in Keratoconjunctivitis sicca(dry eye) for increasing tear productn
#pharma
2) Absorica LD - Feb'20(isotretinoin) capsules in US for severe recalcitrant acne in patients 12yrs&older
3) Ezallor sprinkle - July'19(rosuvastatin)capsules for 3 types of elevated lipid disorders for patients with difficulty in swallowing
#pharma #StockMarket #Nifty #stocks
3) Ezallor sprinkle - July'19(rosuvastatin)capsules for 3 types of elevated lipid disorders for patients with difficulty in swallowing
#pharma #StockMarket #Nifty #stocks
4)Drizalma Sprinkle - Oct'19(duloxetine delayed release capsules) in US for oral use, serotonin & norepinephrine reuptake inhibitor for patients with neuropsychiatric & pain disorders in patients who have difficulty swallowing
@SunPharma_Live annual report 2019/20
#API #sensex
@SunPharma_Live annual report 2019/20
#API #sensex
